The University of Washington training program in the Molecular Pharmacology of Abused Drugs is designed to provide a cohesive training environment for 3 predoctoral and 3 postdoctoral fellows per year, interested in the molecular, cellular and behavioral pharmacological aspects of opioid, cannabinoid, and psychostimulant drug action. The program emphasizes training in research skills along with career development professional skills and responsible conduct of research-ethical skills. Faculty mentors provide training in a broad range of research approaches including molecular pharmacology, electrophysiology, neurochemistry, mouse genetics, viral-based gene expression and behavioral pharmacology. In addition to the general, ongoing training typical at this vibrant institution, trainees in this program experience a coordinated series of events specifically designed for their benefit including invited speaker seminar sessions featuring internationally respected drug abuse researchers;monthly research progress meetings featuring local experts in abused drug research;weekly journal clubs on the current literature of opioid, cannabinoid and psychostimulant research;frequent opportunities for the trainees to enhance their presentation skills;courses organized for them on the 'Molecular Basis of Addiction'and 'Addiction: Mechanisms, Treatment, Prevention';and career development seminars designed to strengthen their scientific and professional foundations. Faculty mentors are highly collaborative, and trainees benefit from a strongly interactive, multidisciplinary research program. The training program will continue to be a catalyst for research collaborations among the participating labs, for technology transfer between labs, and for newly funded collaborative NIDA-research grants. The trainees are drawn from an outstanding pool of candidates recruited to the participating graduate programs in pharmacology and neurobiology and to the well-respected laboratories as post-doctoral fellows. We have an active outreach program designed to encourage participation of underrepresented minorities and fellows from disadvantaged backgrounds. We actively train our students and fellows in responsible conduct of research and ethical treatment of animal subjects. The program is proud of its 20-year history of success in training fellows who have gone on to very successful scientific careers.

Public Health Relevance

This training program is designed to give its predoctoral and postdoctoral fellows essential skills in the study of the molecular basis of drug addiction. Trainees are expected to develop novel research projects that will provide important new insights to the addictive actions of drugs of abuse. These insights are expected to lead to new therapeutic tools for the treatment and prevention of drug addiction.

Agency
National Institute of Health (NIH)
Type
Institutional National Research Service Award (T32)
Project #
3T32DA007278-21S2
Application #
8874455
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Babecki, Beth
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hart, Andrew S; Clark, Jeremy J; Phillips, Paul E M (2015) Dynamic shaping of dopamine signals during probabilistic Pavlovian conditioning. Neurobiol Learn Mem 117:84-92
Gore, Bryan B; Soden, Marta E; Zweifel, Larry S (2014) Visualization of plasticity in fear-evoked calcium signals in midbrain dopamine neurons. Learn Mem 21:575-9
Chavkin, Charles; Schattauer, Selena S; Levin, Jamie R (2014) Arrestin-mediated activation of p38 MAPK: molecular mechanisms and behavioral consequences. Handb Exp Pharmacol 219:281-92
Wang, Wengang; Nitulescu, Ioana; Lewis, Justin S et al. (2013) Overinhibition of corticostriatal activity following prenatal cocaine exposure. Ann Neurol 73:355-69
Wang, Wengang; Darvas, Martin; Storey, Granville P et al. (2013) Acetylcholine encodes long-lasting presynaptic plasticity at glutamatergic synapses in the dorsal striatum after repeated amphetamine exposure. J Neurosci 33:10405-26
Gore, Bryan B; Zweifel, Larry S (2013) Genetic reconstruction of dopamine D1 receptor signaling in the nucleus accumbens facilitates natural and drug reward responses. J Neurosci 33:8640-9
Smith, Jeffrey S; Schindler, Abigail G; Martinelli, Emma et al. (2012) Stress-induced activation of the dynorphin/ýý-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci 32:1488-95
Parker, Jones G; Beutler, Lisa R; Palmiter, Richard D (2011) The contribution of NMDA receptor signaling in the corticobasal ganglia reward network to appetitive Pavlovian learning. J Neurosci 31:11362-9
Parker, Jones G; Wanat, Matthew J; Soden, Marta E et al. (2011) Attenuating GABA(A) receptor signaling in dopamine neurons selectively enhances reward learning and alters risk preference in mice. J Neurosci 31:17103-12
Wall, Valerie Z; Parker, Jones G; Fadok, Jonathan P et al. (2011) A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling. Mol Cell Neurosci 46:21-31

Showing the most recent 10 out of 45 publications